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Letters
Reduction in
ST-Segment Elevation
Cardiac Catheterization
Laboratory Activations
in the United States
During COVID-19 Pandemic
The COVID-19 pandemic has significantly affected the
U.S. health care system. To preserve resources,
including personal protective equipment and hospital
beds to care for COVID-19 patients, the Centers for
Disease Control and Prevention recommended
deferral of elective cardiac procedures (1), including
coronary angiography and percutaneous coronary
intervention for stable coronary artery disease.
Timely reperfusion by means of primary percuta-
neous coronary intervention (PPCI) is the standard of
care for ST-segment elevation myocardial infarction
(STEMI) patients (2). The Society for Cardiac Angiog-
raphy and Interventions and American College of
Cardiology continue to recommend PPCI as the stan-
dard treatment of STEMI patients during the current
pandemic (3). However, anecdotal reports suggest a
decline in PPCI volumes in the United States and
around the world (4).
To determine whether a decrease in PPCI is
occurring in the United States in the COVID-19 era, we
analyzed and quantified STEMI activations for 9 high-
volume (>100 PPCIs/year) cardiac catheterization
laboratories in the United States from January 1, 2019,
to March 31, 2020. Participating hospital systems
included: 1) Minneapolis Heart Institute, Minneap-
olis, Minnesota; 2) Beaumont Hospital Royal Oak,
Royal Oak, Michigan; 3) The Christ Hospital, Cincin-
nati, Ohio; 4) Massachusetts General Hospital, Bos-
ton, Massachusetts; 5) UMass Memorial Medical
Center, Worcester, Massachusetts; 6) Iowa Heart, Des
Moines, Iowa; 7) Northwell Health Hospital, Man-
hasset, New York; 8) Prairie Cardiovascular, Spring-
field, Illinois; and 9) Swedish Medical Center, Seattle,
Washington.
In this study, March 1, 2020, was identified as the
beginning of the “after COVID-19” (AC) period when
U.S. social life and medical operations were signifi-
cantly affected (March 1, 2020, was also the day that
New York City, the epicenter of U.S. COVID-19 cases,
reported its first COVID-19 case). Social distancing
was recommended by the federal government on
March 15, 2020. The “before COVID-19” (BC) period
comprised the 14 months leading up to the epidemic
in the United States (January 1, 2019, to February 29,
2020). We now compared the BC and AC monthly
total and average number of STEMI activations for
each hospital.
A mixed model with random intercepts corrected
for time as a continuous variable was used to estimate
the percent change in STEMI activations in the BC
versus AC period. The model estimate showed a
decrease in STEMI activations of 38% (95% confi-
dence interval: 26% to 49%; p < 0.001). All sites
combined reported >180 STEMI activations every
month (mean 23.6 activations/month) in the BC
period. In contrast, all sites combined reported only
138 activations (mean 15.3 activations/month) in the
AC period (Figure 1).
Our preliminary analysis during the early phase of
the COVID pandemic shows an estimated 38%
reduction in U.S. cardiac catheterization laboratory
STEMI activations, similar to the 40% reduction
noticed in Spain (4). A priori, given the potential
heightened environmental and psychosocial stressors
and a higher case of STEMI induced by viral illness
(e.g., similar to influenza) (5) or mimickers such as
COVID-19 myopericarditis, an increase in STEMI ac-
tivations would have been expected. Potential etiol-
ogies for the decrease in STEMI PPCI activations
include avoidance of medical care due to social
distancing or concerns of contracting COVID-19 in the
hospital, STEMI misdiagnosis, and increased use of
pharmacological reperfusion due to COVID-19. As the
pandemic continues, we plan to continue to follow
this early signal and investigate its causes. It is
particularly crucial to understand if patient-based
anxiety is decreasing presentation of STEMI patients
to the U.S. hospital system.
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FIGURE 1 STEMI Activations During the COVID-19 Pandemic
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(Top left)Map of the United States showing the 9 high-volume ST-segment elevation myocardial infarction (STEMI) centers participating in this registry (yellow stars).
(Lower left) Bar chart displaying average number of STEMI activations per site per month before and after the COVID-19 pandemic affected the U.S. health care
system. (Right panel) Bar chart displaying total number of STEMI activations per month (blue: 2019; red: 2020).
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